The first batch of an experimental Ebola vaccine is heading to Liberia and is expected to arrive Friday.
The shipment of 300 vials, produced by British drug maker GlaxoSmithKline (GSK) and the U.S. National Institutes of Health, is the first potentially preventative medicine to...
